Boehringer Ingelheim Animal Health
GPTKB entity
Statements (52)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:animals
|
gptkbp:acquisition |
gptkb:Vetoquinol
gptkb:Merial |
gptkbp:awards |
Top Employer Europe
Best Employer in Germany |
gptkbp:ceo |
gptkb:Dr._Hubertus_von_Baumbach
|
gptkbp:clinical_trial |
Animal Vaccines
Veterinary Medicines Antiparasitic Products |
gptkbp:collaboration |
Non-Governmental Organizations
Research Institutions Veterinary Associations |
gptkbp:community_involvement |
Animal Shelters
Wildlife Conservation Projects Local Veterinary Clinics |
gptkbp:contribution |
Public Health Initiatives
Veterinary Education Animal Health Research |
gptkbp:employees |
Over 50,000
|
gptkbp:financial_performance |
Revenue in billions
Strong Market Position |
gptkbp:focus |
Veterinary Medicine
|
gptkbp:founded |
1885
|
gptkbp:global_presence |
Over 150 countries
|
gptkbp:has_research_center |
Regional Research Centers
Global Research Center |
gptkbp:headquarters |
Ingelheim am Rhein, Germany
|
https://www.w3.org/2000/01/rdf-schema#label |
Boehringer Ingelheim Animal Health
|
gptkbp:industry |
Pharmaceuticals
|
gptkbp:innovation |
Diagnostics
Biologics Therapeutics |
gptkbp:market |
gptkb:animals
Pets |
gptkbp:part_of |
gptkb:Boehringer_Ingelheim
|
gptkbp:partnership |
gptkb:World_Animal_Health_Organization
Various Veterinary Schools |
gptkbp:products |
Antibiotics
Vaccines Antiparasitics |
gptkbp:research_focus |
Animal Health Products
Animal Vaccines |
gptkbp:strategy |
gptkb:Digital_Transformation
Expansion in Emerging Markets Investment in R& D |
gptkbp:subsidiary |
gptkb:Boehringer_Ingelheim_Gmb_H
|
gptkbp:sustainability_initiatives |
Community Engagement Programs
Animal Welfare Programs Environmental Protection Programs |
gptkbp:website |
www.boehringer-ingelheim.com
|
gptkbp:bfsParent |
gptkb:Boehringer_Ingelheim
|
gptkbp:bfsLayer |
4
|